Healthcare Law Diagnosis — Transactions Part 2: The Role of Regulatory Diligence in Healthcare and How to Prepare for a Sell-Side Transaction (Podcast) – Foods, Drugs, Healthcare, Life Sciences

0


United States: Diagnosed Healthcare Law — Transactions Part 2: The Role of Healthcare Regulatory Diligence and How to Prepare for a Sell-Side Transaction (Podcast)

To print this article, all you need to do is be registered or log in to Mondaq.com.

Health Law Diagnosis Transactions Part 2: Health Regulatory Due Diligence and How to Prepare for a Sales Transaction

Health regulatory due diligence has the ability to make or break a deal. Hear our team’s first-hand experience on the importance of exercising health regulatory due diligence and best practices in preparing for a sale transaction.

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

Surprise! The law without surprises changes again

Dinsmore & Shohl

The No Surprises Act (Act), which took effect on January 1, 2022, is the latest health care law passed with the best intention: to create consumer protection against unexpected out-of-network medical bills and…

Alston and Bird Health Care Week in Review, April 1, 2022

Alston and bird

Below is Alston & Bird’s healthcare week in review, which provides a summary of the latest healthcare regulatory news, advisories and guidance; federal legislation and congressional committee action…

Share.

Comments are closed.